LabCompass

Barbara Kluve‐Beckerman

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex
Amyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatmentsTrace Elements in HealthDrug Transport and Resistance MechanismsPeptidase Inhibition and Analysis

Publications

84

Citations

2,387

Est. group size

—

Recurring co-author estimate

Active years

41

Publishing since 1985

Research summary
AI-generated

Barbara Kluve-Beckerman studies amyloidosis, a group of diseases in which proteins misfold and form abnormal fibril deposits in organs such as the heart, nerves, kidney, and liver. Much of the recent work uses cryo-electron microscopy (cryo-EM) to reveal the detailed structures of amyloid fibrils from patient tissues, alongside cell-based and animal models to understand how these fibrils form and how they might be detected or treated.

Amyloidosis mechanisms and diagnosisCryo-EM structures of amyloid fibrilsTransthyretin (ATTR) amyloid variantsCell and mouse models of amyloid formationProtein misfolding and modification

After several years of low or no recorded output, publication activity increased notably in 2024–2025, indicating a recent surge in structural amyloid studies.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
2017: 1 publication17182019: 4 publications19202021: 2 publications2122232024: 5 publications5242025: 3 publications2526
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×6
  • Amyloid×3
  • Communications Biology×1
  • Structure×1
  • FEBS Letters×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile